Alexis Carrel
Mesenchymal stromal cells for tissue-engineered tissue and organ replacements
Long-term after donation, who are the living kidney donors? *
Very long-term follow-up of living kidney donors
Conversion to tacrolimus once-daily from ciclosporin in stable kidney transplant recipients: a multicenter study
Lack of impact of donor age on patient survival for renal transplant recipients ≥60 years
Comparison of seven liver allocation models with respect to lives saved among patients on the liver transplant waiting list
Early conversion to a sirolimus-based, calcineurin-inhibitor-free immunosuppression in the SMART trial: observational results at 24 and 36 months after transplantation
Outcomes with respect to disabilities of the upper limb after hand allograft transplantation: a systematic review
Human T-cell leukemia virus type 1 infection worsens prognosis of hepatitis C virus-related living donor liver transplantation
The Montreal Criteria for the Ethical Feasibility of Uterine Transplantation
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients
Decreased frequency of peripheral CD4+CD161+ Th17-precursor cells in kidney transplant recipients on long-term therapy with Belatacept
Renal resistive index as a new independent risk factor for new-onset diabetes mellitus after kidney transplantation
Impact of genetic polymorphisms on tacrolimus pharmacokinetics and the clinical outcome of renal transplantation
A 10 min “no-touch” time – is it enough in DCD? A DCD Animal Study
Salvaging kidneys with renal allograft compartment syndrome
Immune thrombocytopenic purpura and Kaposi's sarcoma in a liver transplant recipient
Education and organ donation: ‘the unfinished symphony’
Liver donation after ethylene glycol overdose: when is it safe?